It is not intended for human consumption, medical use, diagnostic use, therapeutic use, weight-loss use, appetite-control use, glucose-management use, diabetes treatment use, obesity treatment use, supplement use, injection use, or the treatment, prevention, or diagnosis of any disease
Further, the expression of neurogenesis-related proteins was promoted by the activation of the cAMP/PKA and Akt/GSK3 signaling pathways through the stimulation of GLP-1R in mice (Wang et al., 2018)
But it sounds like he did his research and knew it wasnt going to be the best option for him
PeptIQ was built specifically for this log your Retatrutide protocol, note how you feel at each dose level, and track your progress over the full cycle
Buyer Takeaway: Standard GLP-1 eligibility thresholds are BMI 30, or BMI 27 with a qualifying comorbidity
Pharmacological approaches to glycemic treatments: standards of care in diabetes 2023